Does oVX1 radioimmunoassay complement CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance procedures?
An elevated OVX1 level can alert oncologists to the possibility that ovarian cancer has persisted, despite the return of CA-125 to a normal range.
A chronic preconditioning-like cardioprotection by regular dipyridamole treatment persists for 3 days after discontinuing therapy. Increased activated Akt and eNOS expression may play a role in this persistent cardioprotection.